In case you missed it: Dec. 14 to Dec. 18
It was a very busy week for the Contemporary OB/GYN® team.
This week’s top articles included:
State of the Industry 2020
COVID-19, racial and gender equality, the rising role of telehealth - many factors converged to make 2020 a year we won’t soon forget. Here is where the industry stands.
Transvaginal ultrasound therapy for symptomatic uterine leiomyomas
A small clinical trial has found that transvaginal high-intensity focused ultrasound (vHIFU) is a promising treatment for women with symptomatic uterine leiomyomas.
Pfizer-BioNTech COVID-19 vaccine authorized for emergency use
U.S. FDA staff have recommended monitoring individuals who get the Pfizer or Moderna vaccine shots for possible cases of Bell’s palsy.
S2E9: Linda Fan, MD, on telehealth in the second stage of COVID-19
This episode of Pap Talk features Linda Fan, MD, an assistant professor of Obstetrics, Gynecology, and Reproductive Sciences; Section Chief of Gynecology; and director of Gynecologic Quality and Safety at the Yale School of Medicine.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
